Stefanos Theoharis

Company: OneChain Immunotherapeutics

Job title: CEO

Seminars:

Generation of highly active Vδ1 gamma delta T cells from stem cells, for the treatment of haematological and solid tumours 11:00 am

Differentiation of Vδ1 gamma delta T cells using Notch ligands using cell-based and cell-free systems CD1a as a target for T-cell ALL using CAR- Vδ1T-cells Advantages versus autologous alphabeta CAR-T cells forT-cell malignanciesRead more

day: Conference Day Two - Track B - AM

Panel Discussion: Reflecting on a Year of Industry Advances: Key Insights from 2023 & Anticipating the Path Ahead in 2024 9:00 am

Reviewing latest clinical updates and identifying key areas of opportunities in the past year Discussing the race to clinic and attracting investors to fund scale ups into the clinic Considering current gamma delta t therapies to drive solid tumor success What does 2024 look like for the field and where is it headed?Read more

day: Conference Day One